Clinicians

MENA’s cardiometabolic crisis is a stability issue

The Transplant Is Not the Finish Line

For Pompe Infants, Time Is the Comparator

Mpox Reached Guinea-Bissau. Stigma Must Not Win.

The Most Preventable Cause of Vision Loss May Still Be Smoking

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach

Chemo Shortages Are Back. So Is Rationing.

Eight Patients Cannot Solve Alzheimer’s. They Can Tell Us What the Next Trial Must Prove.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
